PPARGC1A and fatty liver disease: However, conclusions from clinical studies prevent talking about a beneficial effect of metformin on liver diseases [228]; surely due to the low regulation of PGC-1α that may reduce mitochondrial function and oxidative and proinflammatory environment that further exacerbates hepatic steatosis.